Immunoregulatory gene GIMAP6 suppresses lethal atherosclerotic vasculopathy and ischemic heart failure
By destabilizing the endothelium and promoting macrophage lipid loading and inflammation, GIMAP6 deficiency drives atherosclerosis and ischemic heart disease through a mechanism that operates without hyperlipidemia, yet hyperlipidemia significantly exacerbates disease progression.